Skip to content

To build a precise diagnosis and treatment system for membranous nephropathy based on the correlation between intestinal microecology and TCM tongue diagnosis

To build a precise diagnosis and treatment system for membranous nephropathy based on the correlation between intestinal microecology and TCM tongue diagnosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037508
Enrollment
Unknown
Registered
2020-08-28
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD MN

Interventions

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as primary membranous nephropathy by renal biopsy and clinical examination; 2. Aged 18-75 years old; 3. CKD30ml/min), 24-hour urine protein quantitative >=1g;

Exclusion criteria

Exclusion criteria: 1. Rapidly progressive membranous nephropathy (progressive decline in renal function, necrotizing capillary vasculitis and >50% large crescent formation on renal biopsy); 2. Membranous nephropathy with IgA nephropathy; 3. Have received immunosuppressive drugs or cytotoxic drugs for more than 4 weeks in the past 6 months; 4. Have received glucocorticoids (prednisone or prednisone) at a dose of more than 20 mg/d for more than 4 weeks in the past 6 months; 5. Combined with life-threatening complications such as severe infection; 6. Those with positive HBV serological indicators other than HbsAb and those with abnormal transaminase in continuous liver function tests; 7. Patients with malignant tumors or patients with malignant tumor history, history of HIV infection, history of mental illness, acute central nervous system disease, severe gastrointestinal disease, and patients who are prohibited from using immunosuppressive agents; 8. Abnormal glucose metabolism, fasting blood sugar exceeding 6.2mmol/L; 9. Pregnant or lactating women; 10. Undergoing other clinical trial research; 11. Combined with serious diseases and dysfunction of other organs; 12. Taking probiotics for treatment in the past month; 13. The blood pressure of hypertension is controlled at 130/80mmHg.

Design outcomes

Primary

MeasureTime frame
Scr;ALB;24hupro;

Countries

China

Contacts

Public ContactWANG LIN

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

happytlynn@163.com+86 13585614134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026